MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2024 International Congress

September 27-October 1, 2024. Philadelphia, PA.

View by Title View Sessions
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Environmental Factors are Associated with Disease Severity of LRRK2 Related Parkinson’s Disease and Idiopathic Parkinson’s Disease: a Longitudinal Study

    T. Lüth, A. Caliebe, C. Gabbert, S. Koch, B-H. Laabs, IR. König, C. Klein, J. Trinh (Lübeck, Germany)

  • Environmental risk factors and demographic of patients with Progressive Supranuclear Palsy from Argentina

    F. Rellan, B. Couto, F. Gonzalez Del-Boca, M. Paez Magio, C. Villa, E. Franchello, G. Alvarado, G. Mizraji, D. Nadile, C. Tanner, O. Gershanik, C. Marras (Buenos Aires, Argentina)

  • Epidemiology of Huntington’s Disease in Latin America: A Systematic Review and Meta-analysis.

    A. Medina Escobar, T. Pringsheim, S. Gautreau, J. Rivera-Duarte, G. Amorelli, M. Cornejo-Olivas, M. Rossi (Moncton, Canada)

  • Episodes of Hypoglycemia in Patients with Parkinson’s Disease – Results of Two-Week Continuous Glucose Monitoring

    T. Chmiela, A. Gorzkowska (Katowice, Poland)

  • Essential Tremor: The Relationship Between Hand Dominance and Tremor Severity by MVPA

    AS. Torres-Torres, JR. Dalenberg, AMM. Van-Der Stouwe, MAJ. Tijssen (Groningen, Netherlands)

  • Essential3: An Innovative Multi-Study Phase 3 Program to Evaluate the Efficacy and Safety of Ulixacaltamide

    R. Able, M. Giroux, J. Zhao, H. Jacotin, M. Sniecinski, A. Samaroo, A. La Croix, A. Wyant, C. Santos, M. Souza (Boston, USA)

  • Establishing α-Synuclein Seeding Activity in Saliva as a Noninvasive Diagnostic Biomarker for Parkinson’s Disease

    Z. Wang, S. Gunzler, S. Chen, Q. Kong (Cleveland, USA)

  • Estimating the Proportion of Parkinson’s Disease Clinical Trial Subjects Who Showed No Measurable MDS-UPDRS Motor Score Progression Over 1 Year

    M. Pang, J. Edgerton, L. Zhu, S. Belachew, D. Taylor, C. Kanzler, M. Yang, F. Nahab, C. Shen (Cambridge, USA)

  • Ethnic and Gender Disparities in Access to Deep Brain Stimulation: A Qualitative Exploration

    S. Corrick, J. Miyasaki, K. Yen, B. Salami, P. Torabi, G. Dimapilis, F. Ba (Edmonton, Canada)

  • Ethnic Diversity and Symptomatology in Parkinson’s Disease with a Focus on Falls and Vertical Gaze Palsy

    D. Trivedi, C. Edwards, KC. Dey, E. Camboe, T. Haque, A. Joseph, J. Kahan, D. Gallagher, T. Boyle, C. Budu, B. Huxford, C. Simonet, S. Ganesh, A. Lee, C. Marshall, A. Noyce, A. Zirra (London, United Kingdom)

  • « Previous Page
  • 1
  • …
  • 66
  • 67
  • 68
  • 69
  • 70
  • …
  • 181
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #22901 (not found)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley